Molecular analysis of the breast cancer genes BRCA1 and BRCA2 using amplicon-based massive parallel pyrosequencing

Journal of Molecular Diagnostics

Volumn 14, Issue 6, 2012, Pages 623-630

  Michils, Geneviève ^a   Hollants, Silke ^a   Dehaspe, Luc ^a   Van Houdt, Jeroen ^a   Bidet, Yannick ^b   Uhrhammer, Nancy ^c   Bignon, Yves Jean ^b,c   Vermeesch, Joris R ^a   Cuppens, Harry ^a   Matthijs, Gert ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CENTRE JEAN PERRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT;

ACCURACY; AMPLICON; ARTICLE; BREAST CANCER; CANCER PATIENT; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTANT; OVARY CANCER; POLYMERASE CHAIN REACTION; PYROSEQUENCING; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; OVARIAN NEOPLASMS; OVARY; SENSITIVITY AND SPECIFICITY;

EID: 84867404095     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2012.05.006     Document Type: Article

References (21)

1. M. Margulies, M. Egholm, W.E. Altman, S. Attiya, J.S. Bader, L.A. Bemben, J. Berka, M.S. Braverman, Y.J. Chen, Z. Chen, S.B. Dewell, L. Du, J.M. Fierro, X.V. Gomes, B.C. Godwin, W. He, S. Helgesen, C.H. Ho, G.P. Irzyk, S.C. Jando, M.L. Alenquer, T.P. Jarvie, K.B. Jirage, J.B. Kim, J.R. Knight, J.R. Lanza, J.H. Leamon, S.M. Lefkowitz, M. Lei, J. Li, K.L. Lohman, H. Lu, V.B. Makhijani, K.E. McDade, M.P. McKenna, E.W. Myers, E. Nickerson, J.R. Nobile, R. Plant, B.P. Puc, M.T. Ronan, G.T. Roth, G.J. Sarkis, J.F. Simons, J.W. Simpson, M. Srinivasan, K.R. Tartaro, A. Tomasz, K.A. Vogt, G.A. Volkmer, S.H. Wang, Y. Wang, M.P. Weiner, P. Yu, R.F. Begley, J.M. Rothberg Genome sequencing in microfabricated high-density picolitre reactors Nature 437 2005 376 380
2. K. De Leeneer, I. Coene, B. Poppe, A. De Paepe, K. Claes Rapid and sensitive detection of BRCA1/2 mutations in a diagnostic setting: comparison of two high-resolution melting platforms Clin Chem 54 2008 982 989
3. D. Ford, D.F. Easton, M. Stratton, S. Narod, D. Goldgar, P. Devilee, D.T. Bishop, B. Weber, G. Lenoir, J. Chang-Claude, H. Sobol, M.D. Teare, J. Struewing, A. Arason, S. Scherneck, J. Peto, T.R. Rebbeck, P. Tonin, S. Neuhausen, R. Barkardottir, J. Eyfjord, H. Lynch, B.A. Ponder, S.A. Gayther, M. Zelada-Hedman Breast Cancer Linkage Consortium Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families Am J Hum Genet 62 1998 676 689
4. C. Eng, L.C. Brody, T.M. Wagner, P. Devilee, J. Vijg, C. Szabo, S. Tavtigian, K. Nathanson, E. Ostrander, T. Frank Steering Committee of the Breast Cancer Information Core (BIC) Consortium Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1 J Med Genet 38 2001 824 833
5. T. Wagner, D. Stoppa-Lyonnet, E. Fleischmann, D. Muhr, S. Pagès, T. Sandberg, V. Caux, R. Moeslinger, G. Langbauer, A. Borg, P. Oefner Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations Genomics 62 1999 369 376
6. A.H. van der Hout, A.M. van den Ouweland, R.B. van der Luijt, H.J. Gille, D. Bodmer, H. Brüggenwirth, I.M. Mulder, P. van der Vlies, P. Elfferich, M.T. Huisman, A.M. ten Berge, J. Kromosoeto, R.P.M. Jansen, P.H.A. van Zon, T. Vriesman, N. Arts, M. Boutmy-de Lange, J.C. Oosterwijk, H. Meijers-Heijboer, H.G.E.M. Ausems, N. Hoogerbrugge, S. Verhoef, D.J.J. Halley, Y.J. Vos, F. Hogervorst, M. Ligtenberg, R.M.W. Hofstra A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting Hum Mutat 27 2006 654 666
7. J.P. Schouten, C.J. McElgunn, R. Waaijer, D. Zwijnenburg, F. Diepvens, G. Pals Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification Nucleic Acids Res 30 2002 e57
8. F.B.L. Hogervorst, P.M. Nederlof, J.J.P. Gille, C.J. McElgunn, M. Grippeling, R. Pruntel, R. Regnerus, T. van Welsem, R. van Spaendonk, F.H. Menko, I. Kluijt, C. Dommering, S. Verhoef, J.P. Schouten, L.J. van'T Veer, G. Pals Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method Cancer Res 63 2003 1449 1453
9. S. Agata, M. Dalla Palma, M. Callegaro, M.C. Scaini, C. Menin, C. Ghiotto, O. icoletto, G. Zavagno, L. Chieco-Bianchi, E. D'Andrea, M. Montagna Large genomic deletions inactivate the BRCA2 gene in breast cancer families J Med Genet 42 2005 e64
10. N. Puget, D. Stoppa-Lyonnet, O.M. Sinilnikova, S. Pages, H.T. Lynch, G.M. Lenoir, S. Mazoyer Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions Cancer Res 59 1999 455 461
11. M.R. Stratton, N. Rahman The emerging landscape of breast cancer susceptibility Nat Genet 40 2008 17 22
12. C. Sevilla, J.P. Moatti, C. Julian-Reynier, F. Eisinger, D. Stoppa-Lyonnet, B. Bressac-de Paillerets, H. Sobol Testing for BRCA1 mutations: a cost-effectiveness analysis Eur J Hum Genet 10 2002 599 606
13. D. Goossens, L.N. Moens, E. Nelis, A.S. Lenaerts, W. Glassee, A. Kalbe, B. Frey, G. Kopal, P. De Jonghe, P. De Rijk, J. Del-Favero Simultaneous mutation and copy number variation (CNV) detection by multiplex PCR-based GS-FLX sequencing Human Mutat 30 2008 472 476
14. J. Zhang, R. Chiodini, A. Badr, G. Zhang The impact of next-generation sequencing on genomics J Genet Genomics 38 2011 95 109
15. T. Walsh, M.K. Lee, S. Casadei, A.M. Thornton, S.M. Stray, C. Pennil, A.S. Nord, J.B. Mandell, E.M. Swisher, M.C. King Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing Proc Natl Acad Sci USA 107 2010 12629 12633
16. K. De Leeneer, J. Hellemans, J. De Schrijver, M. Baetens, B. Poppe, W. Van Criekinge, A. De Paepe, P. Coucke, K. Claes Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations Human Mut 32 2011 1 10
17. C.J. Mattocks, M.A. Morris, G. Matthijs, E. Swinnen, A. Corveleyn, E. Dequeker, C.R. Müller, V. Pratt, A. Wallace EuroGentest Validation Group: A standardized framework for the validation and verification of clinical molecular genetic tests Eur J Hum Genet 18 2010 1276 1288
18. R.J.P. Bonnal, M. Severgnini, A. Castaldi, R. Bordoni, M. Iacono, A. Trimarco, A. Torella, G. Piluso, S. Aurino, G. Condorelli, G. De Bellis, V. Nigro Reliable resequencing of the human dystrophin locus by universal long polymerase chain reaction and massive pyrosequencing Anal Biochem 406 2010 176 184
19. S.M. Huse, J.A. Huber, H.G. Morrison, M.L. Sogin, D.M. Welch Accuracy and quality of massively parallel DNA pyrosequencing Genome Biol 8 2007 R143
20. K. De Leeneer, J. De Schrijver, L. Clement, M. Baetens, S. Lefever, S. De Keulenaer, W. Van Criekinge, D. Deforce, F. Van Nieuwerburgh, S. Bekaert, F. Pattyn, B. De Wilde, P. Coucke, J. Vandesompele, K. Claes, J. Hellemans Practical tools to implement massive parallel pyrosequencing of PCR products in next generation molecular diagnostics Plos One 6 2011 e25531
21. S. Ellard, R. Charlton, M. Yau, D. Gokhale, G.R. Taylor, A. Wallace, S.C. Ramsden Practice Guidelines for Sanger Sequencing Analysis and Interpretation Copyright Clinical Molecular Genetics Society, Birmingham, UK http://www.cmgs.org/BPGs/pdfs%20current%20bpgs/Sequencingv2.pdf Approved August 7, 2009